Treffer: Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study
BASE-Bielefeld Academic Search Engine
Anaesthesia
COVIDSurg Collaborative 2021, ' Timing of surgery following SARS-CoV-2 infection : an international prospective cohort study ', Anaesthesia, vol. 76, no. 6, pp. 748-758 . https://doi.org/10.1111/anae.15458
Anaesthesia, 76, 748-758
Anaesthesia, vol 76, iss 6
Anaesthesia, 76(6), 748-758. Wiley-Blackwell
ANAESTHESIA
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Anaesthesia, 76, 6, pp. 748-758
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Anaesthesia, Hoboken : Wiley, 2021, vol. 76, no. 6, p. 748-758
GlobalSurg Collaborative, COVIDSurg Collaborative (2021). Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. Anaesthesia, 76(6), pp. 748-758. Wiley-Blackwell 10.1111/anae.15458 <http://dx.doi.org/10.1111/anae.15458>
1365-2044
Weitere Informationen
Peri-operative SARS-CoV-2 infection increases postoperative mortality. The aim of this study was to determine the optimal duration of planned delay before surgery in patients who have had SARS-CoV-2 infection. This international, multicentre, prospective cohort study included patients undergoing elective or emergency surgery during October 2020. Surgical patients with pre-operative SARS-CoV-2 infection were compared with those without previous SARS-CoV-2 infection. The primary outcome measure was 30-day postoperative mortality. Logistic regression models were used to calculate adjusted 30-day mortality rates stratified by time from diagnosis of SARS-CoV-2 infection to surgery. Among 140,231 patients (116 countries), 3127 patients (2.2%) had a pre-operative SARS-CoV-2 diagnosis. Adjusted 30-day mortality in patients without SARS-CoV-2 infection was 1.5% (95%CI 1.4-1.5). In patients with a pre-operative SARS-CoV-2 diagnosis, mortality was increased in patients having surgery within 0-2 weeks, 3-4 weeks and 5-6 weeks of the diagnosis (odds ratio (95%CI) 4.1 (3.3-4.8), 3.9 (2.6-5.1) and 3.6 (2.0-5.2), respectively). Surgery performed ≥ 7 weeks after SARS-CoV-2 diagnosis was associated with a similar mortality risk to baseline (odds ratio (95%CI) 1.5 (0.9-2.1)). After a ≥ 7 week delay in undertaking surgery following SARS-CoV-2 infection, patients with ongoing symptoms had a higher mortality than patients whose symptoms had resolved or who had been asymptomatic (6.0% (95%CI 3.2-8.7) vs. 2.4% (95%CI 1.4-3.4) vs. 1.3% (95%CI 0.6-2.0), respectively). Where possible, surgery should be delayed for at least 7 weeks following SARS-CoV-2 infection. Patients with ongoing symptoms ≥ 7 weeks from diagnosis may benefit from further delay. ispartof: ANAESTHESIA vol:76 issue:6 pages:748-758 ispartof: location:England status: published